GENOVATE BIOTECHNOLOGY CO LTD has a total of 19 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Taiwan, United States and China. Its main competitors in its focus markets pharmaceuticals are AIRES PHARMACEUTICALS INC, SOM INNOVATION BIOTECH S L and STAYBLE THERAPEUTICS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 5 | |
#2 | United States | 4 | |
#3 | China | 2 | |
#4 | Japan | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wang Yinshan | 7 |
#2 | Lin Yuying | 7 |
#3 | Chen Fengchu | 7 |
#4 | Yang Yilun | 6 |
#5 | Lian Lih-Hua | 3 |
#6 | Yao Li-Fen | 3 |
#7 | Chen Jen | 2 |
#8 | Chang Deh-Ming | 2 |
#9 | Lu Jui-Mei | 2 |
#10 | Yao Li Fen | 1 |
Publication | Filing date | Title |
---|---|---|
US2016199359A1 | System for transdermal treatment of emesis | |
US2016136282A1 | Novel formulation of cilostazol, a quinolinone-derivative used for alleviating the symptom of intermittent claudication in patients with peripheral vascular disease | |
TW201021856A | Antiemetic patch | |
TW200516074A | Synthetic method for the preparation of propiverine hydrochloride | |
US2005014734A1 | Modulation of interleukin-10 by DHEA | |
TW471972B | Taxane composition and method |